Oncolytics Biotech Inc.ONCYNASDAQ
Loading
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +10.33% | +3.20% | +12.48% | +19.59% | +31.55% |
| Weighted Average Shares Diluted Growth | +10.33% | +3.20% | +12.48% | +19.59% | +31.55% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | -83.49% | +353.33% | -12.75% | -95.42% | -48.08% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -47.36% | -48.00% | -43.30% | -37.72% | -37.94% |
| Book Value per Share Growth | -71.71% | -78.97% | -74.86% | -72.19% | -99.03% |
| Debt Growth | +107.00% | +151.54% | -11.27% | -20.43% | -21.52% |
| R&D Expense Growth | +56.82% | -2.28% | -28.90% | -15.68% | +10.61% |
| SG&A Expenses Growth | -18.88% | -15.25% | -1.43% | +17.50% | +100.71% |